SCHEMBL8309835

SCHEMBL8309835

CC(=NO)c1cncc(-c2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 3/20 0.47
MKNK2 Q9HBH9 3/20 0.47
KAT6A Q92794 2/20 0.44
CTSA P10619 1/20 0.41
CASP3 P42574 1/20 0.41
GFER P55789 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
ATM Q13315 1/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 1/20 0.40
XDH P47989 2/20 0.40
SCN2A Q99250 1/20 0.40
SCN10A Q9Y5Y9 1/20 0.40
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1652519 0.80 MKNK2 (0.68) MKNK1MKNK2KAT6ACTSACYP11B1
SCHEMBL4327798 0.79 KMO (0.52) CASP3GFERSENP8SENP7SENP6
SCHEMBL8310029 0.79 KMO (0.52) CASP3GFERSENP8SENP7SENP6
Biphenyl SCHEMBL27563074 0.78 CYP1A2 (0.50) CASP3GFERSENP8SENP7SENP6
SCHEMBL1477488 0.77 MAPT (0.47) CASP3GFERSENP8SENP7SENP6
SCHEMBL1477491 0.77 MAPT (0.47) CASP3GFERSENP8SENP7SENP6
SCHEMBL8685836 0.77 MKNK1 (0.43) MKNK1MKNK2KAT6ACTSACYP11B1
SCHEMBL3368876 0.77 SMN1; SMN2 (0.56) CASP3GFERSENP8SENP7SENP6
SCHEMBL4316450 0.77 SMN1; SMN2 (0.56) CASP3GFERSENP8SENP7SENP6
Hydrochloric Acid SCHEMBL1477554 0.76 MAPT (0.46) CASP3GFERSENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed